Page last updated: 2024-09-05

regadenoson and Benign Neoplasms, Brain

regadenoson has been researched along with Benign Neoplasms, Brain in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anders, NM; Figg, WD; George, RT; Gilbert, M; Grossman, SA; Harfi, TT; Jackson, S; McAreavey, D; Nduom, EK; Peer, C; Rudek, MA; Weingart, J; Ye, X	1
Cai, Q; Carson, RE; Gao, X; Grutzendler, J; Han, L; Holden, D; Huang, Y; Kong, DK; Li, L; Ma, C; Murikinati, S; Park, JH; Piepmeier, JM; Thomas, JL; Tian, D; Ye, C; Yuan, P; Zheng, MQ; Zhou, J	1

Trials

1 trial(s) available for regadenoson and Benign Neoplasms, Brain

Article	Year
The effect of an adenosine A Fluids and barriers of the CNS, 2018, Jan-15, Volume: 15, Issue:1 Topics: Adenosine A2 Receptor Agonists; Administration, Intravenous; Administration, Oral; Adult; Aged; Antineoplastic Agents, Alkylating; Brain; Brain Neoplasms; Dacarbazine; Feasibility Studies; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Purines; Pyrazoles; Receptor, Adenosine A2A; Temozolomide	2018

Article

Year

The effect of an adenosine A

Fluids and barriers of the CNS, 2018, Jan-15, Volume: 15, Issue:1

Topics: Adenosine A2 Receptor Agonists; Administration, Intravenous; Administration, Oral; Adult; Aged; Antineoplastic Agents, Alkylating; Brain; Brain Neoplasms; Dacarbazine; Feasibility Studies; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Purines; Pyrazoles; Receptor, Adenosine A2A; Temozolomide

2018

Other Studies

1 other study(ies) available for regadenoson and Benign Neoplasms, Brain

Article	Year
Increased Nanoparticle Delivery to Brain Tumors by Autocatalytic Priming for Improved Treatment and Imaging. ACS nano, 2016, 04-26, Volume: 10, Issue:4 Topics: Animals; Antineoplastic Agents; Biological Transport; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Decanoic Acids; Drug Delivery Systems; Ethanolamines; Female; Genetic Therapy; Heterografts; Humans; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; Nanoparticles; Optical Imaging; Paclitaxel; Permeability; Polymers; Purines; Pyrazoles; Scorpion Venoms; Transcytosis; Tumor Microenvironment	2016

Article

Year

Increased Nanoparticle Delivery to Brain Tumors by Autocatalytic Priming for Improved Treatment and Imaging.

ACS nano, 2016, 04-26, Volume: 10, Issue:4

Topics: Animals; Antineoplastic Agents; Biological Transport; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Decanoic Acids; Drug Delivery Systems; Ethanolamines; Female; Genetic Therapy; Heterografts; Humans; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; Nanoparticles; Optical Imaging; Paclitaxel; Permeability; Polymers; Purines; Pyrazoles; Scorpion Venoms; Transcytosis; Tumor Microenvironment

2016